ArticleRespirology case reports2026

First-Line Lorlatinib in Striatin-Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma: A Case Report and Literature Review.

Masaru Maebeya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.